MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Select Medical Holdings Co. (NYSE:SEM – Free Report) by 4.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 61,591 shares of the health services provider’s stock after purchasing an additional 2,694 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.’s holdings in Select Medical were worth $1,161,000 as of its most recent SEC filing.
A number of other large investors also recently added to or reduced their stakes in the company. Smartleaf Asset Management LLC raised its holdings in shares of Select Medical by 179.0% in the 4th quarter. Smartleaf Asset Management LLC now owns 2,296 shares of the health services provider’s stock valued at $43,000 after buying an additional 1,473 shares during the period. Covestor Ltd lifted its position in shares of Select Medical by 33.5% during the fourth quarter. Covestor Ltd now owns 4,955 shares of the health services provider’s stock worth $93,000 after purchasing an additional 1,244 shares in the last quarter. Lazard Asset Management LLC boosted its stake in shares of Select Medical by 47.8% in the fourth quarter. Lazard Asset Management LLC now owns 6,974 shares of the health services provider’s stock valued at $130,000 after purchasing an additional 2,255 shares during the period. Quarry LP grew its holdings in shares of Select Medical by 963.0% in the fourth quarter. Quarry LP now owns 9,078 shares of the health services provider’s stock valued at $171,000 after purchasing an additional 8,224 shares in the last quarter. Finally, HBK Investments L P purchased a new stake in Select Medical during the 4th quarter worth approximately $188,000. 89.48% of the stock is currently owned by institutional investors and hedge funds.
Insider Buying and Selling
In related news, CEO David S. Chernow sold 225,000 shares of the business’s stock in a transaction dated Monday, April 28th. The stock was sold at an average price of $18.00, for a total value of $4,050,000.00. Following the transaction, the chief executive officer now owns 714,516 shares in the company, valued at $12,861,288. The trade was a 23.95% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Parvinderjit S. Khanuja acquired 21,000 shares of Select Medical stock in a transaction on Monday, May 5th. The shares were bought at an average cost of $15.02 per share, with a total value of $315,420.00. Following the completion of the purchase, the director now owns 65,089 shares in the company, valued at $977,636.78. The trade was a 47.63% increase in their ownership of the stock. The disclosure for this purchase can be found here. 11.60% of the stock is currently owned by company insiders.
Select Medical Stock Performance
Select Medical (NYSE:SEM – Get Free Report) last issued its earnings results on Thursday, May 1st. The health services provider reported $0.44 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.45 by ($0.01). Select Medical had a net margin of 3.23% and a return on equity of 14.04%. The company had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.40 billion. During the same quarter in the previous year, the company posted $0.75 EPS. The company’s quarterly revenue was down 24.4% on a year-over-year basis. Research analysts predict that Select Medical Holdings Co. will post 1.17 EPS for the current fiscal year.
Select Medical declared that its board has initiated a share buyback plan on Thursday, May 1st that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the health services provider to reacquire up to 42.6% of its shares through open market purchases. Shares repurchase plans are typically an indication that the company’s management believes its stock is undervalued.
Select Medical Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Thursday, May 29th. Investors of record on Thursday, May 15th will be given a $0.0625 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $0.25 dividend on an annualized basis and a dividend yield of 1.74%. Select Medical’s dividend payout ratio (DPR) is presently 18.66%.
Analyst Upgrades and Downgrades
Several research firms have commented on SEM. Mizuho began coverage on shares of Select Medical in a research note on Wednesday, April 16th. They issued an “outperform” rating and a $25.00 price target for the company. Benchmark upgraded Select Medical from a “hold” rating to a “buy” rating and set a $23.00 price target on the stock in a report on Monday, February 24th. Royal Bank of Canada decreased their price objective on Select Medical from $23.00 to $19.00 and set an “outperform” rating for the company in a research note on Wednesday, May 7th. Finally, Wall Street Zen raised Select Medical from a “hold” rating to a “buy” rating in a research report on Friday, February 21st. One investment analyst has rated the stock with a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Select Medical presently has an average rating of “Moderate Buy” and an average target price of $26.00.
Check Out Our Latest Report on Select Medical
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Stories
- Five stocks we like better than Select Medical
- When to Sell a Stock for Profit or Loss
- This Market Sell-Off Might Trigger a Value Rotation Into Pepsi
- What is an Earnings Surprise?
- Alphabet Stock LagsāBut Waymo May Be Its Hidden Driver
- Trading Halts Explained
- Trade Desk Silences Critics; Recovery Looks Poised to Continue
Want to see what other hedge funds are holding SEM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Select Medical Holdings Co. (NYSE:SEM – Free Report).
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.